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1. Introduction 
Proteins serve many purposes by acting as structural supports, receptors, signaling 
molecules and enzymes, in addition, they facilitate nutrient transport and maintain 
immunological responses. Although the concentration of a given protein may not change 
appreciably over a short interval, proteins are continuously remodeled. In this chapter we 
consider how to study protein kinetics. Attention is directed towards two critical areas 
which include (i) the logic behind using different tracers and (ii) how to design and execute 
experiments that are compatible with proteome-based analyses.  
A practical illustration may highlight the importance of using isotope tracers to facilitate 
research in this area. For example, the concentration of circulating albumin provides a 
measure of protein nutritional status (and is a predictor of a patient’s recovery from 
disease), however, since the fractional turnover of albumin is relatively slow (~ 3 to 5% of 
the pool is newly made per day) several weeks of an intervention may be required to affect 
plasma levels. Recognizing that the concentration of albumin is a delayed-onset marker of 
nutritional status, investigators have used isotope tracers to determine the acute response of 
plasma albumin synthesis to a dietary manipulation, accordingly, one can make predictions 
regarding the efficacy of an intervention. Such studies rely on straightforward experimental 
designs. Namely, an investigator first decides on what amino acid will be used (e.g. 2H3-
leucine) and how will it be administered (e.g. a primed-constant infusion), samples are then 
collected for a given amount of time and a protein of interest (e.g. albumin) is isolated. Once 
isolated, the protein of interest is degraded (typically via acid hydrolysis) and the labeling of 
the free amino acid present in the plasma is compared to that of the amino acid that was 
bound in the protein, i.e. one determines the precursor:product labeling ratio. Although this 
scenario is relatively straightforward, our review considers the pros and cons surrounding 
the use of different tracers. In particular, we discuss recent advances in the use of stable 
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isotope protocols that enable more flexible study designs, including the use of 2H and 18O-
labeled water. 
The second objective of this chapter aims to consider the utility of modern proteomic 
methods. For example, in the scenario described above, it is imperative that one purify the 
protein(s) of interest otherwise a study will reflect the kinetics of a mixture of proteins. 
Despite the fact that one can extensively purify proteins using immunoprecipitation, gel 
electrophoresis, etc. those approaches are typically labor intensive. Other methods, e.g. 
"shotgun" proteomics, can facilitate the resolution of complex mixtures with a minimum of 
time required for sample preparation, the trade-off is an increase in the amount of time 
required to process large data sets. It may not be obvious to investigators getting started in 
this area but the acquisition parameters that are often used in proteome-based studies are 
not necessarily compatible with the use of stable isotope-based flux protocols. In addition, 
investigators are often faced with questions such as, is one type of mass spectrometer 
"better" than another for determining the isotopomer profile? We discuss our experiences in 
estimating protein flux using proteome-based analyses.  
In summary, proteome expression profiles contain information regarding differences 
between metabolic states yet they are typically of limited value when one aims to explain 
the nature of those differences. We consider approaches that should allow investigators to 
perform studies of proteome dynamics and therein move from static expression profiles 
towards kinetic/mechanistic studies. Where possible, attention is directed towards 
applications that can be used to advance the study of circulating proteins, especially those 
that relate to the field of lipoprotein kinetics. We apologize to investigators who do not have 
their work cited herein, where possible we have tried to identify papers that demonstrate 
necessary conceptual points and/or represent the initial publications in a given area. 
2. Using stable isotope tracers to study protein synthesis and degradation 
Rates of protein synthesis can be determined by administering a labeled precursor and then 
measuring its incorporation into a protein of interest (Figure 1) (Foster et al. 1993;Wolfe and 
Chinkes 2005). Assuming a simple model, in which there is a well-mixed pool of amino 
acids and a single product compartment, one can describe the kinetics using equation 1: 
 protein labeling time = protein labeling max x (1- e-FSR x time) (1) 
where protein labeling max represents the asymptotic labeling of a protein and FSR 
represents its fractional synthetic rate. By measuring the labeling at multiple points in time 
one can fit the curve and determine FSR. In cases where a steady-state labeling is not 
reached one typically estimates the kinetics using equation 2: 
 FSR = pseudo-linear change in protein labeling / (precursor labeling x time) (2) 
We consider the following example to demonstrate the effect that timing of sample 
collection can have on estimating the FSR, in this case we have simulated the labeling of 
proteins with different FSRs (Figure1). Panel A demonstrates that fitting an entire data set to 
Equation 1 yields the expected FSR. Panel B demonstrates a comparable fit of the data using 
reduced data sets, fitting the points obtained only at 4 hour intervals to Equation 1 yields the 
expected FSR. Note that it may not be practical to obtain extensive data sets in all cases 
(Figure 1A vs B), e.g. one may be limited in regards to blood or tissue sampling, as well,  
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Fig. 1. Effects of modeling on data interpretation. Simulations were run to determine the 
effect(s) of calculation methods on apparent fractional synthetic rates. Panel A demonstrates 
a scenario wherein the protein labeling was simulated assuming three rate constants, i.e. 
FSR = 0.02, 0.2 and 0.4 per hour. Fitting all data points in a given curve using Equation 1 
yields the expected rate constants. Panel B demonstrates the effect(s) of using various 
truncated data sets on apparent FSR. Again, fitting all data in a given curve to Equation 1 
yields rate constants that closely agree with the expected values. However, it is possible to 
substantially underestimate the FSR when using single points, e.g. using Equation 2 and 
data obtained only at 4 hours leads to estimates of FSR equal to 0.199, 0.137 and 0.019 per 
hour, as compared to the expected values of 0.4, 0.2 and 0.02 per hour, respectively.  
limiting the number of data points increases the throughput since fewer samples need to be 
analyzed. Panel B also demonstrates the effect of using Equation 2, for example, what would 
happen if we only obtained data 4 hours after administering a tracer? Clearly there is a 
reasonable estimate of FSR when the true value is relatively low (~ 0.02) but there is a 
sizeable underestimate of the FSR in cases where one expects it to equal ~ 0.4 and ~ 0.2. 
Although the apparent FSR values reported in Panel B are different from the expected 
values (i.e. when using Equation 2 and the sample obtained at 4 hours), one can still identify 
differences between the curves, i.e. the expected FSR of 0.4 yields a value of 0.199 whereas 
the expected FSR of 0.2 yields a value of 0.137. The effect of this error becomes important in 
cases where one aims to determine the magnitude of an intervention. For example, there is a 
2-fold difference between the true FSR values (i.e. 0.4 vs 0.2) yet the apparent FSR values 
only differ by ~ 1.5-fold (i.e. 0.199 vs 0.137). Therefore, the timing of sample collection has 
important consequences on the interpretation of the data and the conclusions one may reach 
regarding physiological homeostasis. 
Although the mathematics surrounding tracer kinetics have been described in detail (Foster 
et al. 1993;Wolfe and Chinkes 2005), there are certain caveats that apply in different fields. 
For example, investigators working in the area of lipoprotein kinetics have recognized the 
need to add delays in the modeling (Barrett, Chan, and Watts 2006;Foster et al. 
1993;Patterson et al. 2002). Namely, although proteins such as apolipoprotein B are 
continuously synthesized within liver and/or intestine, they are not immediately secreted 
into the circulation. Consequently there is a lag time between the administration of a tracer 
and the appearance of labeled apolipoprotein B in the plasma. Foster et al. (Foster et al. 1993) 
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have elegantly outlined the rationale behind different mathematical treatments of a given 
data set, they demonstrate the impact of various assumptions in regards to the modeling of 
data on the apparent FSR. It is also important to note the differences when modeling data 
that are expressed as a tracer-to-tracee ratio vs isotopic enrichment, the former is commonly 
reported but the latter may be preferred in many instances (Cobelli, Toffolo, and Foster 
1992;Ramakrishnan 2006;Toffolo, Foster, and Cobelli 1993). 
A second major factor to consider regarding the logic that is applied in kinetic studies 
centers on heterogeneity in the product pool (note that there are concerns regarding 
heterogeneity in labeling of the precursor pool, those will be considered in more detail in 
Section 3) (Foster et al. 1993). To this point we have assumed a simple model in which there 
is a single pool of product molecules, however, investigators working in the area of 
lipoprotein kinetics readily recognize the existence of at least two pools of circulating 
apoB100, one that is associated with VLDL particles and another that is associated with LDL 
particles (Lichtenstein et al. 1990). While there has been some debate regarding whether or 
not LDL-apoB100 is made de novo or whether it is derived from the delipidation of VLDL it 
is clear that the labeling curves are dramatically different (Lichtenstein et al. 1990;Shames 
and Havel 1991). In a classical study, Lichtenstein et al.(Lichtenstein et al. 1990) 
demonstrated that the labeling of VLDL-apoB100 approaches a steady-state in ~ 15 hours 
whereas the labeling of LDL-apoB100 is still in the pseudo-linear range during the same 
interval; those studies also demonstrated that there are sizeable differences in the 
abundance of VLDL-apoB100 vs LDL-apoB100 (Figure 2).  
What are the consequences of estimating the FSR of apoB100 from the total labeling, i.e. if 
one ignores the fact that a small amount of the protein is typically labeled much faster than 
the bulk pool of apoB? Consider the scenario outlined in Figure 2, the lumped fractional rate 
constant does not reflect either of the individual fractional rate constants. In addition, 
although directional changes in the lumped fractional rate constants reflect true changes, the 
magnitude is underestimated. On the contrary, the ability to measure the absolute flux rate 
(i.e. the mass of protein made per unit of time) allows one to draw conclusions regarding 
true changes in the flux, however, one is not able to determine the site of those changes (e.g. 
Was a single pool affected? If so, which one?). We consider how to estimate protein 
concentration later. 
A final question to consider regarding protein kinetics is centered on quantifying protein 
breakdown (Figure 3). As noted above, the incorporation of a tracer into a protein of interest 
can be used to estimate the rate of synthesis, can one estimate the rate of protein breakdown 
by measuring the elimination of a tracer from a protein of interest? We believe that the 
answer is "no", or at the very least it is not as straightforward as reports in the literature 
(Bateman et al. 2006;Bateman et al. 2007). Readers should consider how measurements of 
isotopic labeling are typically performed and how data are expressed. For example, 
investigators often use a mass spectrometer to determine isotopic labeling and express data 
as the ratio of labeled to unlabeled molecules (or the percentage of labeling, i.e. the labeled 
molecules divided by the sum of labeled and unlabeled molecules) (Dwyer et al. 
2002;Lichtenstein et al. 1990;Magkos, Patterson, and Mittendorfer 2007). We agree that in 
cases where one infuses a labeled amino acid for a given time and then stops the infusion of 
the tracer that there will be a decrease in the labeling of a given protein over time (Figure 3) 
(Bateman et al. 2006;Bateman et al. 2007). However, assuming that protein breakdown is a 
random process, i.e. protein breakdown does not discriminate between labeled and 
unlabeled molecules, the ratio of labeled to unlabeled protein molecules will not change as  
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Fig. 2. Effect(s) of lumping pools. Simulations were run to determine the impact of treating a 
mixed pool as single compartments (open circles represent unlabeled proteins and solid 
circles represent labeled proteins). For example, apoprotein-B100 is found in VLDL and LDL 
particles in the plasma. The mass of apoB100 is ~ 5 to 40 times different between these 
compartments, as well the FSR is considerably different. Assume that VLDL-apoB100 has an 
FSR of ~ 0.4 and a pool size of ~ 5 molecules whereas LDL-apoB100 has an FSR of ~ 0.05 and 
a pool size of ~ 20 molecules. If one isolated the individual apolipoprotein pools the 
aforementioned values would be obtained, however, if one isolated total apoB100 from the 
plasma the fractional "lumped" synthesis rate would equal ~ 0.12 (3 out of 25 molecules). 
Now, assume an inhibitor of VLDL-apoB100 is added such that the FSR of VLDL-apoB100 
decreases to ~ 0.2 (for simplicity, assume a parallel change occurs in protein degradation so 
that the pool size remains constant). If one isolates total apoB100 from plasma the fractional 
"lumped" synthesis rate would equal ~ 0.08 (2 out of 25 molecules). Clearly one would 
observe a decrease in synthesis but the true effect is substantially underestimated (i.e. the 
true reduction is 50% in VLDL-apoB100 vs 33% reduction detected in total apoB100). 
Accounting for the pool size, however, allows one to reliably determine the true change in 
apoB100 synthesis, i.e. a total 3 molecules are newly made during the basal period vs 2 
during the inhibited period. 
www.intechopen.com
 
Integrative Proteomics 
 
238 
 
time
%
 l
a
b
e
li
n
g
amino acid infusion
fractional synthesis rate fractional catabolic rate ?
protein
amino acid
%
 l
a
b
e
li
n
g
 
Fig. 3. Tracer-based estimates of protein breakdown. During the infusion of a labeled amino 
acid (dotted line) one can estimate protein synthesis by determining the change in protein 
labeling (solid line). Following the infusion of a labeled amino acid one expects a "washout" 
or a decrease in the labeling. As shown here, however, the rate at which the protein labeling 
decreases is dependent on the rate of protein synthesis and not protein breakdown. Note 
that the y-axis is expressed as “% labeling” (consistent with reports in the literature). A 
major assumption of any tracer method is that the tracer and tracee are indiscriminately 
metabolized, therefore, after one stops administering a labeled precursor amino acid the 
labeling in the protein can only decrease if new protein is made in absence of labeled 
precursor amino acids.  
the protein is degraded; the labeling decreases because new proteins are being made from 
unlabeled precursors (Previs et al. 2004;Waterlow 2006).  
We believe that it is possible to estimate protein breakdown using the following logic, 
changes in the abundance of a protein equal the rate of synthesis minus the rate of 
breakdown. Protein breakdown can be determined by measuring the abundance of a protein 
and estimating the rate of synthesis, i.e. one solves the equation for protein breakdown 
(Bederman et al. 2006). Section 4 considers the merits of different approaches for measuring 
the abundance of a protein. It should also be emphasized that the ability to measure the 
abundance of a protein is important in cases where one aims to determine a rate of flux (i.e. 
the mass of protein that is being renewed per unit of time). For example, to this point we 
have focused on measuring a fractional rate constant (or a percent of a pool that is turned 
over per unit of time), one can calculate the absolute amount of newly made protein per unit 
of time by multiplying the FSR by the pool size (i.e. concentration multiplied by the volume 
of distribution). In studies of apolipoprotein kinetics, the pool size is typically assumed to 
equal the plasma volume which is estimated to be 4.5% of body weight (Lichtenstein et al. 
1990;Magkos, Patterson, and Mittendorfer 2007). In cases where one aims to study the 
kinetics of other circulating proteins, for example albumin, it may be necessary to account 
for distribution between the extravascular and intravascular spaces (Sigurdsson, Shames, 
and Havel 1981;Wasserman, Joseph, and Mayerson 1955).  
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3. How can I label the precursor pool? 
Our discussion of protein synthesis is entirely focused on the logic of using 
precursor:product labeling ratios to estimate rates of flux, we are not examining cases in 
which one injects a pre-labeled protein and then measures its kinetics. Therefore, one should 
consider how to label the amino acid building blocks used in protein synthesis (Figure 4). 
Perhaps the most obvious design that comes to mind centers on administering a labeled 
amino acid (Dudley et al. 1998;Lichtenstein et al. 1990), however, investigators have also 
administered other labeled precursors (e.g. 13C-glucose, 2H2O and H218O) (Bernlohr 
1972;Bernlohr and Webster 1958;Borek, Ponticorvo, and Rittenberg 1958;Busch et al. 2006;De 
Riva et al. 2010;Rachdaoui et al. 2009;Rittenberg, Ponticorvo, and Borek 1961;Vogt et al. 
2005;Wykes, Jahoor, and Reeds 1998). Before discussing the merits of specific approaches we 
briefly consider the mode of administering the labeled precursor, e.g. a labeled amino acid 
can be administered as a primed-constant infusion or a single bolus injection (Dwyer et al. 
2002;Lichtenstein et al. 1990;Wolfe and Chinkes 2005).  
The general logic behind the primed-constant infusion is that one can instantaneously achieve 
and then maintain a steady-state labeling of the precursor pool (Lichtenstein et al. 1990), 
whereas a single bolus injection is typically associated with a wave (or pulse) of labeling 
(Dwyer et al. 2002). A concern with using a primed-constant infusion is that one must have 
catheterized subjects, while certainly feasible in human studies this is not as practical in many 
pre-clinical models (especially in drug discovery programs where large numbers of 
compounds are routinely screened). However, a pro of the primed-constant infusion centers 
on the degree of product labeling that can be achieved, this can be rather dramatic in studies of 
apolipoprotein kinetics. For example, when investigators have administered 2H3-leucine using 
a primed-constant infusion the plasma pool can be enriched to nearly 10% for several hours 
(Lichtenstein et al. 1990). Although some proteins have a rapid turnover others are labeled to a 
much lesser degree, e.g. the FSR of VLDL-apoB100 and HDL-apoA1 are in the range of ~ 5 and 
~ 0.2 pools per day and the labeling typically approaches 7% and 0.75%, respectively.  
In contrast to a primed-infusion, when administering a single bolus of 2H3-leucine the 
labeling of VLDL-apoB100 and HDL-apoA1 approaches ~ 2.5% and ~ 0.25%, respectively 
(Dwyer et al. 2002). These differences in protein flux impact the isotopic labeling and have 
important implications on the analytical methods that are used to measure the enrichment. 
One might be able to enhance the use of a bolus injection method by choosing (i) an essential 
amino acid and/or (ii) an amino acid with a relatively long half-life. For example, one 
expects less dilution of essential amino acids since they can only be produced by one source 
(protein breakdown and not de novo synthesis), as well, compared to some non-essential 
amino acids (which participate in rapid inter-organ nitrogen transport) the t1/2 of essential 
amino acids can be relatively slow. It is not surprising that 13C-lysine has been used to make 
SILAC models (Kruger et al. 2008), since lysine is needed in relatively small amounts 
complete substitution of unlabeled lysine for 13C-labeled lysine can be managed. The same 
types of experiments with 13C-alanine would probably be of limited value since alanine is 
rapidly turned over and it sits at a highly branched point in intermediary metabolism 
(Wykes, Jahoor, and Reeds 1998). Nevertheless, in limited cases 13C-glucose has been used to 
quantify protein synthesis (Figure 4). For example, 13C-glucose is converted 13C-pyruvate 
which readily equilibrates with alanine to yield 13C-alanine, entry of 13C-pyruvate into the 
citric acid cycle will generate other 13C-labeled amino acids via comparable equilibration 
reactions (Vogt et al. 2005;Wykes, Jahoor, and Reeds 1998). 
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Fig. 4. Approaches to labeling amino acids. Panel A considers a straightforward method in 
which a labeled amino acid is administered. Panel B considers a scenario in which labeled 
glucose is administered; glycolytic metabolism will lead to the labeling of several amino 
acids. Note that an abbreviated metabolic scheme is shown to emphasize certain points of 
exchange, other amino acids can become labeled as well. Panel C considers the 
administration of labeled water. In cases where 2H2O is administered it is expected that de 
novo synthesized amino acids will be labeled, as well, amino acids derived from protein 
breakdown will be labeled provided that amino acid turnover is faster than the rate of 
amino acid incorporation into newly made protein. In cases where H218O is administered 
one expects “instantaneous” labeling of amino acids regardless of their origin.  
Another stable isotope that has seen substantial use is 15N-glycine. Historically, this tracer 
was administered and the excretion of 15N-urea and/or 15N-ammonia was used to estimate 
the rate of whole-body nitrogen flux (San Pietro and Rittenberg 1953a;San Pietro and 
Rittenberg 1953b). Note that although investigators administer 15N-glycine, the isotope 
rapidly mixes (or equilibrates) with other amino acid bound nitrogens which is the rationale 
for using it to trace "total" nitrogen flux (Matthews et al. 1981;Stein et al. 1980). More 
recently investigators have fed 15N-labeled diets to animals in an effort to generate heavily 
labeled proteins that could then be used as internal standards to quantify protein 
concentrations in other subjects (MacCoss et al. 2005). In clever studies, Price et al. (Price et 
al. 2010) and Zhang et al. (Zhang et al. 2011) fed mice 15N-labeled diets and were then able to 
estimate proteome turnover. The advantage of feeding 15N-labeled diets as compared to a 
single labeled amino acid (e.g. 13C-lysine) is that numerous protein-bound nitrogens will be 
labeled, therein increasing the window when measuring shifts in the isotope distribution of 
a proteolytic-peptide.  
A final approach to label the precursor pool centers on the administration of labeled 
water, either 2H2O or H218O (Figure 4C) (Cabral et al. 2008;De Riva et al. 2010;Kombu et al. 
2009;Rachdaoui et al. 2009;Xiao et al. 2008). The rationale is that cells will generate labeled 
amino acids in the presence of labeled water, e.g. 2H-labeling can occur via transamination 
and/or de novo synthesis. In contrast to the generation of 13C-labeled amino acids from 
13C-glucose, which does not label essential amino acids, in the presence of 2H2O one can 
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observe 2H-labeling of essential amino acids (Herath et al. 2011a). Namely, although 
essential amino acids are not made in a net sense (i.e. 13C-glucose does not yield 13C-
leucine), transamination of leucine in 2H2O will label the -hydrogen. Despite the fact that 
studies based on the use of labeled water revolutionized our understanding of metabolic 
biochemistry nearly 80 years ago there appears to have been a dramatic shift away from 
the use of labeled water in the field of protein dynamics for reasons that remain unclear 
(Borek, Ponticorvo, and Rittenberg 1958;Schoenheimer and Rittenberg 1938;Ussing 
1938;Ussing 1941;Ussing 1980).  
We, and others, have recently revisited the use of 2H2O in studies of protein synthesis 
(Busch et al. 2006;Cabral et al. 2008;De Riva et al. 2010;Kombu et al. 2009;Previs et al. 
2004;Rachdaoui et al. 2009;Xiao et al. 2008), we also recognized the potential advantage(s) of 
using H218O (Bernlohr 1972;Bernlohr and Webster 1958;Borek, Ponticorvo, and Rittenberg 
1958;Rachdaoui et al. 2009;Rittenberg, Ponticorvo, and Borek 1961). Our use of H218O was 
based on a classical study in which Rittenberg and colleagues demonstrated that H218O 
could be used to study protein synthesis (the outstanding contributions of Bernlohr and 
others further tested the approach and more clearly outlined the logic) (Bernlohr 
1972;Bernlohr and Webster 1958;Borek, Ponticorvo, and Rittenberg 1958;Rittenberg, 
Ponticorvo, and Borek 1961). Unlike 2H2O which labels amino acids in a less uniform 
manner, H218O is expected to label virtually all amino acids to a similar degree. For example, 
oxygen in the carboxylic group can be labeled during de novo production, the degradation of 
proteins and/or the activation of amino acids (Figure 4C). Indeed, modern quantitative 
proteomic methods rely on this logic albeit for a different purpose, i.e. proteolytic cleavage in 
the presence of H218O leads to the generation of 18O-labeled peptides (Miyagi and Rao 
2007;Yao et al. 2001).  
One point to consider when thinking about using different tracers, e.g. 2H3-leucine vs H218O 
vs 2H2O, is the background labeling over which one measures the incorporation. Since these 
are all stable isotopes one needs to contend with background labeling, e.g. naturally 
occurring 13C and 15N account for ~ 1.1% and ~ 0.4% of all carbon and nitrogen, respectively, 
and make substantial contributions to the isotope profile over which one measures excess 
labeling from the administered tracer (note that other isotopes also affect the background 
labeling but to a lesser degree since they are present at lower abundance (e.g. 2H, 17O and/or 
18O) and/or are less prevalent (e.g. 33S or 34S) in various proteins. The use of heavily 
substituted precursors, e.g. 2H3-leucine, could be advantageous since the background 
labeling is lower at the M+3 isotopomer whereas the use of 2H2O and H218O typically 
requires that one measure shifts in the M+1/M0 and M+2/M0 ratios, respectively (where 
the background labeling can be considerably higher). Consequently, the impact of analytical 
error is expected to be somewhat worse when measuring the M+1/M0 ratio vs the M+3/M0 
ratio since the background is higher. One can minimize the effect of analytical error by 
administering more tracer and/or relying on the fact that multiple copies of a precursor are 
incorporated into a given protein (e.g. it is possible to incorporate more copies of 2H from 
body water as compared to 2H3-leucine). These points are explained below in more detail. 
Last, in cases where one administers a pre-labeled amino acid (e.g. 2H3-leucine) one is 
immediately limited when quantifying protein synthesis since it is necessary to identify 
those peptides that contain the designated amino acid (e.g. 2H3-leucine). In contrast, when 
using a more general tracer, e.g. 2H2O or H218O, it is possible to quantify protein synthesis 
via the labeling of various proteolytic peptides.  
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4. What should I consider when measuring the labeling of a protein? 
In studies of protein synthesis one needs to compare the labeling of the product with that of 
the precursor. Although this section is primarily centered on the application of proteomic-
based analyses for measuring the former, we will first briefly consider measurements of 
precursor labeling.  
Several methods have been developed to measure the labeling of free amino acids; 
presumably, GC-quadrupole-MS-based methods are so commonplace since the hardware 
was readily available during the early 1980s when the use of stable isotopes began to 
dominate the literature (Matthews et al. 1980). In addition, these instruments have 
reasonable spectral accuracy therein allowing reliable estimates of isotope distributions. 
Typical protocols require a purification step (often using ion exchange chromatography) 
followed by derivatization prior to GCMS analyses. Although there are pros and cons to the 
generation of different derivatives (e.g. tertbutyldimethylsilyl vs N-acetyl-n-propyl, vs 
oxazolinone derivatives) (Dwyer et al. 2002;Matthews et al. 1980;Patterson, Carraro, and 
Wolfe 1993) it is clear that excellent precision of the isotope ratios can be achieved using 
standard equipment, for example, the coefficient of variation in the measured isotope ratios 
is often ≤ 1.0%, ensuring a certain degree of confidence when measuring the labeling of free 
amino acids. In cases where one decides to administer either 2H2O or H218O (and therein 
allow the subject to generate labeled amino acids) it is necessary to measure the 2H- or 18O-
labeling of water (Rachdaoui et al. 2009). Historically, IRMS was used to measure water 
labeling, however, simple and robust GC-quadrupole-MS-based methods are available for 
measuring the 2H and 18O-labeling of water (Brunengraber et al. 2002;Shah et al. 2010;Yang 
et al. 1998). 
So then, how can investigators couple isotope tracers with proteomic-based analyses? In our 
experience we have generally faced two major issues when addressing this question. First, 
how reproducible are the mass spectrometer-based measurements? Second, what type of 
instrument is the best? Although the two questions are somewhat related we will consider 
them separately.  
During our earlier work we considered alternative approaches to processing the raw data 
(Cassano et al. 2007;Wang et al. 2007). For example, our initial studies were conducted with 
a mostly out-of-date Bruker MALDI-ToF, we devised a strategy in which we would 
download the raw data and then fit the isotopic distributions to a series of Gaussian peaks 
(this was done using the commercially available software package "Origin"). One reason for 
devising this approach centered on the fact that the relatively low resolution achieved on the 
isotope peaks was not easily integrated using the instrument's software. Please note that the 
statements made here are not intended to reflect poorly on any vendor, in our previous 
academic experiences we simply had limited access to state-of-the-art equipment. In 
developing our earlier work (Cassano et al. 2007;Wang et al. 2007), we performed numerous 
simulations to ensure the reliability of our approach for integrating the data and therein 
evaluating how the quality of the primary data would impact the results of the fitting 
routine, we consider two examples that may be of interest (Figure 5).  
Briefly, simulations were run in which 3 Gaussian shaped peaks were generated (e.g. M0, 
M1 and M2 ions), noise was added using the random number generator in MS Excel; the 
expected ratios for M1/M0 and M2/M0 were set at 70% and 30%, respectively, and the 
resolution was set at ~ 30% valley between peaks (this resolution setting was chosen since it 
compared with what we had observed on the older Bruker MALDI-ToF, which did not  
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S/N ~ 10, ~ 60 data points
areaM1/M0 = 69.0 ± 0.9
areaM2/M0 = 30.9 ± 1.1
Chi2/DoF = 12, r2 = 0.968
S/N ~ 25, ~ 60 data points
areaM1/M0 = 69.7 ± 0.3
areaM2/M0 = 30.2 ± 0.2
Chi2/DoF = 2, r2 = 0.990
S/N ~ 100, ~ 60 data points
areaM1/M0 = 69.9 ± 0.2
areaM2/M0 = 30.1 ± 0.1
Chi2/DoF = 0.2, r2 = 0.999
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 S/N ~ 10, ~ 125 data points
areaM1/M0 = 70.2 ± 0.5
areaM2/M0 = 29.7 ± 0.5
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S/N ~ 10, ~ 25 data points
areaM1/M0 = 68.8 ± 1.3
areaM2/M0 = 29.4 ± 1.1
Chi2/DoF = 14, r2 = 0.921
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areaM1/M0 = 69.0 ± 0.9
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Fig. 5. Determining isotopic distributions. Simulations were run to determine the effect(s) of 
data quality and fitting on the calculated isotope ratios. In all cases 3 Gaussian shaped peaks 
were generated (e.g. M0, M1 and M2 ions); noise was added using the random number 
generator in MS Excel, the expected ratios for M1/M0 and M2/M0 are 70% and 30%, 
respectively, and the resolution was set at ~ 30% valley between peaks (note that this 
resolution setting was chosen for our simulations since it corresponded with the data that 
we were obtaining with an older Bruker MALDI-ToF when run in a linear mode, a 
somewhat worst-case senario). The simulated data were exported to Origin and fitted 
assuming a Gaussian model, each simulation was run 5 times, data are expressed as mean ± 
sem of the measured ratios. In Panels A, B and C we maintained a constant number of data 
points across the M0, M1 and M2 cluster (~ 60 data points) and we varied the S/N. In panels 
D, E and F, we maintained a constant and relatively low S/N (~ 10) and varied the number 
of data points. In all cases, there is reasonably good agreement between the measured and 
expected ratios.  
always cooperate when run in the reflectron, or high-resolution, mode). In each example ~ 
60 data points were observed across the 3 peaks, each simulation was run 5 times and data 
are expressed as mean ± sem of the measured ratios (Figure 5A, B and C). The study 
demonstrates that our integration method yields a reliable quantification of isotopomer 
profiles, in all cases there was good agreement between measured:expected ratios. This 
study is especially useful since protein analyses typically have to contend with peptides at 
different abundance, e.g. a given digest may contain peptides at S/N ~ 10 whereas others 
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may be present at S/N ~ 100. Thus, we can estimate the level of confidence when 
determining the isotopic profiles of peptides with low vs high S/N. Although this example 
implies that a somewhat wide range of abundances can be used to estimate protein labeling, 
we suggest that it is best to focus quantitations on those peptides that are in greatest 
abundance since the precision generally improves. 
A second scenario to consider in regards to data processing centers on the number of points 
that one observes across a series of peaks, this can be affected by various factors including 
the amount of sample that is analyzed, the type of mass analyzer and the analog-to-digital 
conversion rate. Our previous work mostly relied on the analyses of relatively pure samples, 
consequently, we primarily used MALDI-ToF (Rachdaoui et al. 2009). In our current work 
we almost exclusively rely on LC-MS since less purification is required prior to analysis 
(Kasumov et al. 2011;Zhou et al. 2011). Since one expects that coupling LC to a 
“discriminating” mass analyzer (e.g. a quadrupole) will reduce the number of data points 
that are used to describe a peptide’s isotopomer profile we ran simulations to determine 
how the number of data points would affect the fitting/quantitation of the isotopic profile 
(Figure 5D, E and F). As in the previous example, the expected values of M1/M0 and 
M2/M0 are 70% and 30%, respectively, and the resolution was set at ~ 30% valley between 
peaks (the simulation was run 5 times so that data could be expressed as mean ± sem of the 
measured ratios). Although the simulations were run at a low S/N (~ 10, a somewhat worst-
case scenario), it is possible to reasonably fit the peaks even when as few as ~ 25 points are 
recorded across the 3 isotopes in the profile (Figure 5F).  
The examples described above are less about the type of mass spectrometer and more about 
the processing of raw data. In our current studies, the commercially available software 
appears to be generally sufficient for obtaining relatively precise measures of isotope 
clusters. Thus the need for extra effort in regards to data processing may not be justified in 
all cases. However, an area where data processing may be worth considering centers on 
using FT-ICR MS (MacCoss et al. 2005). Reports in the literature have discussed a potential 
bias against isotope peaks present at low abundance (Bresson et al. 1998;Erve et al. 2009), 
recent efforts by our colleagues have started to address those apparent limitations (Ilchenko 
et al. 2011). We suspect that LC-FT-ICR MS analyses may offer another unique advantage 
when quantifying low levels of 2H-labeling. For example, we have demonstrated the ability 
to quantify low levels of 2H-labeling by resolving the M+1 isotope peak into its 13C and 2H 
components (Herath et al. 2011b).  
To this point we have not considered the acquisition mode under which data would be 
collected, the examples noted above do not imply MS or MS/MS-based analyses. Indeed, a 
substantial portion of our previous work was centered around MS-based analyses with less 
effort towards examining MS/MS-based measurements (Rachdaoui et al. 2009;Wang et al. 
2007). Some of the advantages to using MS/MS analyses include (i) enhanced signal:noise, 
(ii) reduced concerns for overlapping peptides by identifying and characterizing the labeling 
of numerous fragments and (iii) sequence information on the peptide. The acquisition of 
MS/MS data to determine isotopic composition on a Q-ToF instrument is demonstrated 
using an apoA1 derived peptide (Figure 6). The doubly charged parent ion (m/z 520.85) is 
isolated at low-resolution in the quadrupole and then fragmented, the daughter ions are 
detected with the ToF analyzer. It is important to note that the relative intensities of the 
daughter ion profiles are close to the predicted natural abundance and the expected shift in 
the mass isotopomer distribution to higher isotopic composition with increased mass is  
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Fig. 6. LC-Q-ToF spectra of ARPALEDLR. The acquisition of MS/MS data to determine 
isotopic composition on a Q-ToF instrument are demonstrated using the apoA1 derived 
peptide ARPALEDLR. The doubly charged parent ion (m/z 520.8) is isolated at low-
resolution in the quadrupole, fragmented by CID and the daughter ions detected with the 
ToF analyzer. The relative intensities of the daughter ion profiles are in close agreement 
with the predicted natural abundance (insets), the expected shift in the mass isotopomer 
distribution to higher isotopic composition with increased mass is readily apparent by the 
increase in the M1/M0 ratio of the daughter ions. Note that the insets show changes in 1 
amu for isotope clusters at 288.23, 753.49 and 813.55 vs a shift of 0.5 amu for the cluster at 
520.85 since these correspond with singly vs doubly charge species, respectively. 
readily apparent by the increase in the M1/M0 ratio. These data are in agreement with a 
recent study in which we demonstrated the ability to measure the labeling of individual 
amino acids in tryptic peptides (Kasumov et al. 2011). We suspect that MS/MS-based 
measurements may need to consider the instrument configuration. For example, triple 
quadrupole measurements are likely to be good but have an inherent bias since one must 
decide what transitions to monitor. In contrast, Q-ToF measurements have the potential to 
capture more data and appear to have good reproducibility in regards to quantifying 
isotope labeling patterns (Castro-Perez et al. 2010). 
The next question to address is, can one perform studies of proteome turnover? We consider 
what this would require for plasma-based analyses. First, although the concentration range 
of the plasma proteome varies from ~ 35 x 109 pg albumin per ml vs ~ 5 pg interleukin-6 per 
ml, mass spectrometers are flexible enough to identify and quantify analytes across this 
range (Anderson et al. 2004;Anderson and Anderson 2002). These seemingly positive 
statements lead into a consideration of the central problem, i.e. assuming that one can detect 
a protein can one determine its kinetics? Based on our experience, since the signal:noise can 
play an important role in affecting the apparent labeling the answer is a clear "maybe". We 
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believe that the demands of measuring the mass isotopomer profile of a single peptide 
conflict with the imperative of identifying the largest number of peptides, making LC-MS 
protocols employed in proteomic studies less than ideal for some tracer-based protein 
turnover studies. For example, in preliminary work with an ion trap mass spectrometer, we 
observed that determination of a peptide’s mass isotopomer profile with sufficient precision 
to quantify 2H-incorporation required that the zoom scan mode be used with multiple scans 
encompassing an entire peptide chromatographic peak. In principle, this scan sequence (full 
scan to identify peptides that are present and zoom scan on a desired peptide) conflicts with 
an emphasis on obtaining data on the largest number of peptides characteristic of proteomic 
studies. We originally thought that these conflicting demands on the acquisition parameters 
of the mass spectrometer would limit protein turnover analyses to a smaller number of 
peptides than are present in the proteome. However, by generating a list of previously 
identified peptides, from proteins of interest, it should be possible to determine protein 
turnover rates on 10-100 proteins for a given LC-MS run.  
Two recent publications deserve special attention. Namely, Price et al. (Price et al. 2010) used 
a hybrid LTQ/FT instrument to measure turnover of ~2500 proteins in multiple tissues of 
mice fed with 15N-labeled algae, their MS/MS method consisted of one survey scan 
followed by several secondary scans of selected ions. Likewise Zhang et al. (Zhang et al. 
2011) fed mice an E. coli-derived 15N-labeled protein mixture. Samples were analyzed using 
an Orbitrap instrument, full scans at high resolution (~ 60,000 at m/z 400) were used for 
isotopic distribution analysis; they identified and quantified the kinetics on ~ 700 proteins 
using a novel software package. It is important to emphasize that in both cases (Price et al. 
2010;Zhang et al. 2011), the investigators observed a substantial mass shift because ~ 100% 
of the diet was labeled, the utility of these analytical approaches needs to be examined when 
the peptide labeling results in more subtle changes in isotopic distribution. In addition, 
corrections for inherent spectral error are also needed (Erve et al. 2009). Alternatively, in 
cases where a complex matrix is obtained, the fractionation of protein classes or the isolation 
of targeted analytes can be used to enhance the application of this method (Figure 7), e.g. 
prior to digestion/analyses the samples were subjected to immunodepletion to remove 
several high abundance proteins. 
As discussed earlier, the ability to quantify shifts in the isotopic labeling allow one to 
estimate the FSR, however, in certain instances it is of interest to determine the absolute rate 
of synthesis (which requires an estimate of the concentration of a given protein). Numerous 
techniques can be used to measure the concentration of a protein (or peptides) (Gygi et al. 
1999;Gygi et al. 2000;Jaleel et al. 2006;Johnson and Muddiman 2004;van Eijk and Deutz 
2003;Yao et al. 2001;Zhang et al. 2001), however, each requires special considerations when 
applied in combination with a tracer study. First, in regards to labeling methods such as 
ICAT, one assumes equal generation and recovery of labeled and unlabeled species before 
mixing and analyzing. We believe that those techniques are of limited value in some studies. 
For example, if one administers 2H2O to quantify protein synthesis, some reagents (e.g. 
ICAT or digestion in H218O) may not induce a large enough shift in the peptide mass to 
allow one to comfortably measure the 2H-labeling profile and determine protein synthesis. 
For example, suppose that one aims to determine the synthesis and concentration of apoE, 
which has a t1/2 that is estimated to be < 1 hour in rodents (Figure 7). The rate of synthesis 
can be determined by measuring the 2H-labeling of an apoE-derived peptide. The change in 
concentration can be determined by digesting a 0 min sample in H2O and digesting a 60 min  
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Fig. 7. Labeling of mouse apoproteins. Comparable labeling profiles were observed for 
several apoproteins in C57BL/6J mice given either 2H2O or H218O. Note that animals were 
given an intraperitoneal bolus of either tracer and then allowed free access to labeled 
drinking water, as shown in the inset mice exposed to 2H2O reached a steady-state labeling 
whereas mice exposed to H218O demonstrated a slight decrease in the labeling of body 
water. As expected, there were sizeable differences in the labeling of the various 
apoproteins, the relative differences are consistent with the literature, e.g. the FSR of apoE ~ 
apoB > apoA1. The magnitude of the labeling reflects variation in the amino acid 
composition of the respective peptides and the t1/2. Data are shown as the mean ± standard 
deviation, n = 3 per time point.  
sample in H218O and then mixing the samples and comparing the relative 18O-labeling in a 
given peptide. However, the presence of 18O (for quantifying abundance) will likely 
interfere with measurements of 2H-labeling (protein synthesis). Therefore, each sample 
would likely need to be analyzed duplicate (first to determine the 2H-labeling to estimate 
the rate of synthesis and second to determine the 18O- or ICAT-labeling to estimate the 
concentration). 
The use of SILAC methods is more likely to be compatible with the use of tracers in flux 
studies, i.e. one adds a known amount of a heavily labeled protein mixture and then 
compares the abundance of the cold peptides with that of heavily labeled SILAC peptides 
(Ong et al. 2002). While it is clear that SILAC methods are well suited for cell-based and 
rodent studies (Kruger et al. 2008), a potential drawback centers on the fact that it is not 
possible to fully label many model systems (e.g. humans). Interestingly, recent studies have 
demonstrated dynamic SILAC (Andersen et al. 2005;Doherty et al. 2009), i.e. investigators 
used a SILAC approach for administering a tracer but focused their attention on quantifying 
the change in labeling of numerous proteins in order to determine their flux. It is important 
to note that the early reports regarding the SILAC approach (for quantitative proteomics) 
clearly demonstrated the potential for quantifying proteome kinetics (we refer the readers to 
Figure 3 of (Ong et al. 2002)). Mann and colleagues monitored the temporal changes in 
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protein labeling to determine when the cells had become fully labeled, from that point they 
knew that they had generated SILAC cells which could be used to determine the protein 
expression profiles of other cells (Ong et al. 2002); despite the fact that their major objective 
was to contrast SILAC and ICAT methods for determining protein expression profiles, they 
demonstrated the potential for determining proteome turnover. 
We believe that a simple and reasonable approach for determining protein abundance, 
which is compatible with the administration of a tracer for determining proteome kinetics, 
centers on the use of label-free methods. For example, Wang et al.(Wang et al. 2003) reliably 
quantified numerous peptides by measuring their relative abundance during a given run. 
Although this approach requires attention to detail during the sample processing and a 
stable operating system, it is immediately compatible with tracer-based studies since the 
isotopic labeling patterns are not altered. Clearly, there are factors that may skew the data 
resulting in estimates of concentrations that are far from the correct value (e.g. ion 
suppression effects), nevertheless, label-free methods can be used infer relative 
concentrations and differences between groups (Wang et al. 2003;Wiener et al. 2004). We 
should note that in cases where one aims to determine the kinetics of a single protein 
and/or a select group of proteins it is possible to use custom synthesized standards, e.g. this 
strategy has been used for measuring insulin concentration (Kippen et al. 1997;Stocklin et al. 
1997). A related approach would be to use an “isomer dilution” strategy (Thevis et al. 2005), 
e.g. when studying the kinetics of albumin and/or insulin in rodents one could spike 
samples with known amounts of human albumin and insulin before processing and 
analyses.  
5. Interpretation of the precursor: Product labeling ratio 
Assuming that one has devised a strategy to administer a precursor and one has found a 
suitable way to measure its incorporation into a protein, there is a final question that must 
be addressed, how do I interpret the precursor:product labeling ratio? We first consider the 
scenario in which an investigator has administered a pre-labeled amino acid(s) and later 
consider the novelty of administering either 2H2O or H218O.  
As noted earlier, the goal of a primed-infusion is that one will instantaneously achieve and 
then maintain a steady-state labeling of a given amino acid tracer. Indeed, this was clearly 
demonstrated by Lichtenstein and colleagues, they simultaneously administered multiple 
labeled amino acids and observed the incorporation of each into various apoproteins 
(Lichtenstein et al. 1990). However, although the labeling of VLDL-apoB100 approaches a 
steady-state by the end of the infusion protocol the enrichment of amino acids in VLDL-
apoB100 is substantially lower than the enrichment of those free amino acids in plasma. 
Although it is not possible to state with certainty the source of this discrepancy, it is clear 
that the transport of free amino acids into the cell (and/or mixing with the endogenous 
pool) must be slower than the rate of intracellular protein breakdown (Khairallah and 
Mortimore 1976) which likely results in marked compartmentation. What are the 
consequences of this on estimates of protein synthesis? One does not expect problems when 
the aim is to fit the exponential labeling curve (e.g. collect multiple time points and use 
Equation 1), in those cases the FSR is estimated from the time it takes to reach steady-state 
and it does not necessarily matter how labeled the protein is at steady-state (the caveat, 
however, is that one expects a better fit in cases where the asymptotic value is greatest since 
there is a large change in labeling over the natural background) (Figure 1A) (Foster et al. 
www.intechopen.com
Proteome Kinetics: Coupling the Administration of  
Stable Isotopes with Mass Spectrometry-Based Analyses 
 
249 
1993). In cases where one aims to determine the synthesis of protein with a small FSR it may 
be necessary to use Equation 2, therefore, any error in the apparent precursor labeling will 
have an immediate impact on the estimated FSR. Based on data in the literature, if one 
assumes that the intracellular labeling equals the plasma labeling one will likely 
underestimate the FSR of LDL-apoB100 by nearly 2-fold since the labeling of amino acids in 
plasma is ~ 2 times greater than the estimated intracellular amino acid labeling (Lichtenstein 
et al. 1990). Note that in many studies, the production of VLDL-apoB100 is not only a 
parameter of interest but it serves a critical function in estimating LDL-apoB100 production, 
HDL-apoA1 production, etc. As discussed, the asymptotic labeling of VLDL-apoB100 may 
be used as a surrogate to estimate the precursor labeling that is needed to calculate LDL-
apoB100 and HDL-apoA1 production (Lichtenstein et al. 1990). For example, LDL-apoB100 
and HDL-apoA1 have relatively slow rates of synthesis and therefore show pseudo-linear 
increases in labeling over a short term infusion. As such, it is not practical to model the data 
and estimate FSR using Eq 1; to estimate the FSR of LDL-apoB100 and/or HDL-apoA1 
investigators often use Eq 2 and substitute the asymptotic labeling of VLDL-apoB100 as the 
precursor labeling (Lichtenstein et al. 1990). The scenario discussed here applies to most 
cases in which cells are labeled from the outside, e.g. the administration of a pre-labeled 
amino acid. 
One expects more reliable estimates of flux in cases where cells are labeled from the inside 
provided that one can determine the intracellular precursor labeling. For example, the 
administration of 13C-glucose leads to the generation of 13C-amino acids (Figure 4) but the 
labeling of those amino acids is likely to be diluted by carbon exchange (Wykes, Jahoor, and 
Reeds 1998). In cases where labeled water is used one expects comparable labeling between 
intracellular and extracullar pools. Dietschy and colleagues clearly demonstrated that water 
readily distributes in the plasma and that plasma labeling reflects tissue-specific labeling 
almost instantly (Dietschy and Spady 1984;Jeske and Dietschy 1980). As we have described 
previously, it is possible to then estimate protein flux by comparing the change in the 
labeling of proteolytic-peptides with that of body water (Rachdaoui et al. 2009). The caveat 
is that one must account for the number of copies of the precursor that are incorporated, 
referred to as n (Cabral et al. 2008;Kasumov et al. 2011;Rachdaoui et al. 2009;Xiao et al. 2008). 
For example, in cases where H218O is administered, the labeling of the protein will exceed 
that of the precursor since one expects that each peptide bond will incorporate 18O. Note 
that in the example shown in the inset for Figure 7 the labeling of water is ~ 2.5 to 3.0% yet 
the labeling of the various proteins greatly exceeds those levels, therefore one needs to 
correct the precursor:product labeling ratio by including a constant for n (Herath et al. 
2011a;Rachdaoui et al. 2009). 
6. Summary and conclusions 
We believe that it is possible to readily convert static protein expression profiles into 
dynamic images. Numerous approaches are available for tracing protein synthesis and 
various strategies have been implemented for measuring the labeling of peptides in complex 
mixtures. We believe that there is no single best method but certain fundamental points 
should be recognized. For example, the administration of a labeled precursor can present a 
challenge for in vivo studies. The administration of labeled water may be advantageous in 
these settings, the tracer can be given orally, it is relatively inexpensive and can be used to 
study multiple parameters simultaneously (this is especially important in studies of 
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lipoprotein kinetics since questions regarding protein and lipid flux are often of equal 
importance) (Castro-Perez et al. 2010;Castro-Perez et al. 2011;Dufner and Previs 2003). In 
contrast, although we have demonstrated the ability to study protein synthesis in cell 
culture using labeled water (Dufner et al. 2005), we believe that SILAC methods are 
generally superior for in vitro studies since it is trivial to completely substitute fully labeled 
amino acids for unlabeled amino acids in that setting.  
In regards to the analyses of protein mixtures, we believe that there is no single best MS 
approach. Although our applications have been focused on small groups of proteins, it is 
clear that the labeling profiles of analytes present in complex mixtures can be sorted out; 
again, the SILAC literature strongly supports these conclusions. We believe that an area 
which will likely have an important impact on future studies centers on data processing; in 
our experience the MS hardware may be limited by the software. As we have demonstrated 
it is possible to obtain reliable isotopic ratios using commercially available software, 
however, in some cases alternative methods have been of great value.  
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